Investment
Features
FeesSafety
Academy
More
Pluang+

US group seeks CFTC approval for AI compute price futures to manage cost risks

Market News
20 Oct 2026
Tokenpost
View Source
Neutral
US group seeks CFTC approval for AI compute price futures to manage cost risks

The Hyperliquid Policy Center (HPC) has requested the U.S. Commodity Futures Trading Commission (CFTC) to allow regulated U.S. exchanges to list futures and perpetual contracts based on AI compute prices, such as GPU-hour rental and AI inference token prices. These contracts aim to help businesses like data centers, AI developers, and lenders hedge against the volatility of computing costs. HPC also proposes standards for compute price indexes, options for different settlement indexes, and market safeguards to prevent manipulation. This request is separate from Payward's plan to offer onchain perpetual futures through Hyperliquid's HIP-3 framework, which awaits regulatory approval. The CFTC has sought public comments but has not yet approved these contracts.

The Hyperliquid Policy Center's request to the CFTC for AI compute futures comes with Pluang market context for major cryptocurrencies as of Oct 21, 2026 02:31 WIB: out of 50 priced assets, 44 rose and 5 fell. Among movers, AXS rose 5.20% to Rp18.925 despite 100% sell order activity, contrasting with VET's 4.80% rise to Rp126 where buy orders slightly outnumbered sells at 51%. GRT increased 4.71% to Rp448 even as sell orders dominated at 94%.

More News

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
43 minutes ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
48 minutes ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
1 hour ago
Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...

Analyst Insights
Bullish
1 hour ago
Brunello Cucinelli raises 2026 outlook after strong Q3 sales, Citigroup keeps Buy rating.

Brunello Cucinelli raises 2026 outlook after strong Q3 sales, Citigroup keeps Buy rating.

Brunello Cucinelli, an Italian luxury fashion company, raised its 2026 outlook following stronger-than-expected third-quarter sales. Citigroup maintains a Buy rating on the stock, which trades around $9.43 with a market cap of approximately $6.41 bil...

Analyst Insights
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App